Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Donlinon Jan 10, 2018 3:42pm
124 Views
Post# 27327024

RE:RE:This price is a joke...

RE:RE:This price is a joke...
V111, not sure why you are buying.  Just too many questions that have not been answered.
Some are:
o how is TLT financially surviving?  With 1.7M in the bank as of Apil 2017 and burn rate of $350K/Mth, the wallet should be empty by now.  
o what is the status of the TLC 2000 and its redesign.  Is it on schedule?
o what is the status of bladder clinical studies.  The timeline was YE or may be into 1Q18.  A status would be nice on whether it is progressing as anticipated.

A lot of fluff announcements about possible cancer cures which is nice to hear but I would like to hear about events/$$$ scenarios that will support a higher stock price.  Unfortunately, the delay is only creating an environment where the stock will soon be in the teens.
Bullboard Posts